Special Project Angiogenesis
Clinical Trials
PDQ Clinical Trial Search
The list of clinical trials shown below was obtained by the
NCI Anti-Angiogenesis Clinical Trials List
. View each trial individually by clicking the title.
Click here for more
Cancer Links
Phase I Study of Carboxyamidotriazole Modulated by Ketoconazole in Patients with Advanced Malignancies
Phase II Study of CAI in Patients with Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Phase II Randomized Study of Oral Thalidomide in Hormone-Refractory Adenocarcinoma of the Prostate
Phase II Study of Oral Carboxyamidotriazole in Patients with Androgren-Independent Prostate Cancer
Phase II Study of Suramin for Metastatic Melanoma
Phase II Randomized Study of Oral Thalidomide in Metastatic Breast Cancer
Phase II Study of Oral Thalidomide in HIV-Associated Kaposi's Sarcoma
Phase I Study of Oral COL-3 in Patients with Refractory Metastatic Solid Tumors or Lymphoma
Phase II Pilot Study of Suramin for Refractory or Relapsed Multiple Myeloma and Castleman's Disease
Phase I/II Pilot Study of Interleukin-12 for AIDS-Associated Kaposi's Sarcoma
Phase II Study of Suramin for Recurrent Primary Adult Brain Tumors
Phase II Study of Suramin in Advanced Nonsmall Cell Lung Cancer
Phase II Study of TNP-470 for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix
Phase III Randomized Study of Marimastat versus Placebo in Patients with Metastatic Breast Cancer Who Have Responding or Stable Disease After Induction Chemotherapy
Phase II Study of Suramin for Recurrent or Progressive Malignant Glioma
Phase I Study of Carboxyamidotriazole plus Paclitaxel for Advanced Solid Tumors and Refractory Lymphomas
Phase III Randomized Study of TNP-470 vs Synchronous Radiotherapy and 5-FU/CF for Locally Advanced Nonresectable Nonmetastatic Pancreatic Cancer
Phase I Study of Carboxyamidotriazole for Refractory Cancers
Phase I Study of TNP-470 in Patients with Recurrent or Refractory Pediatric Solid Tumors, Lymphomas, and Acute Leukemias
Phase III Randomized Study of Marimastat in Patients with Small Cell Lung Cancer Following a Response to First Line Chemotherapy
Special
Project Angiogenesis